Chugai Pharmaceutical (OTC:CHGCF) Stock, Quote.Headers.trade-ideas

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

News

Penny Stocks

Health Care

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

ABBV

ABOS

ALXO

ANVS

ARGNF

CHGCF

HALO

RHHBY

Halozyme Therapeutics (NASDAQ: HALO) announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which is produced using the company&#39;s proprietary ENHANZE manufacturing methods.

Halozyme&#39;s ENHANZE Product Gets New Patent Grant in EU

CHUGAI PHARMACEUTICAL by Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co Ltd

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript

Chugai Pharmaceutical Co (JP:4519) has released an update. Chugai Pharmaceutical Co. reports that its performance for the first half of 2024 has be...

Chugai Pharmaceutical Included in Roche's 2024 Results

Chugai Pharmaceutical Co (JP:4519) has released an update. Chugai Pharmaceutical Co., Ltd. reports a solid performance in the first half of FY 2024...

Chugai Pharmaceutical's H1 Profits and Dividends Up

Chugai Pharmaceutical reports 1H results

Chugai Pharmaceutical Co (JP:4519) has released an update. Chugai Pharmaceutical Co., Ltd. has announced corrections to its previously disclosed 20...

Chugai Pharmaceutical Corrects Financial Statements

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript

Invesco Developing Markets Fund Q2 2024 Quarterly Review

Harding Loevner International Equity Q2 2024 Report

Harding Loevner International Equity ADR Q2 2024 Report

Harding Loevner International Developed Markets Equity Q2 2024 Report

AAUKF

ADYEY

ADYYF

ASAZF

ASAZY

ASML

ASMLF

BBVA

BBVXF

BHPLF

BNDSF

BNDSY

BSAC

CHGCY

DBSDF

DBSDY

FMXUF

GBOOF

GBOOY

GLPEF

GLPEY

GMAB

GMBXF

GNMSF

HTHT

IFNNF

IFNNY

INFY

LZRFY

MDTTF

MPLX

MPLXP

NGLOY

NHNCF

NONOF

NSRGF

NSRGY

NVDA

PAAPU

PDRDF

PRNDY

SAPGF

SBGSF

SBGSY

SGIOF

SGIOY

SNEJF

SONY

SSNLF

TCEHY

TCTZF

TSMWF

USAC

WMMVF

WMMVY

YUMC

ZTOEF

Chugai Pharmaceutical

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Chugai Pharmaceutical

Chugai Pharmaceutical (CHGCF) Forecast

Chugai Pharmaceutical (OTC:CHGCF) Stock, Quote.Headers.trade-ideas